Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Enhanced Osteogenic Differentiation in Zoledronate-Treated Osteoporotic Patients.

Dalle Carbonare L, Mottes M, Malerba G, Mori A, Zaninotto M, Plebani M, Dellantonio A, Valenti MT.

Int J Mol Sci. 2017 Jun 13;18(6). pii: E1261. doi: 10.3390/ijms18061261.

2.

Osteoporosis drug effects on cortical and trabecular bone microstructure: a review of HR-pQCT analyses.

Lespessailles E, Hambli R, Ferrari S.

Bonekey Rep. 2016 Aug 31;5:836. doi: 10.1038/bonekey.2016.59. eCollection 2016. Review.

3.

Rheumatoid Arthritis Exacerbates the Severity of Osteonecrosis of the Jaws (ONJ) in Mice. A Randomized, Prospective, Controlled Animal Study.

de Molon RS, Hsu C, Bezouglaia O, Dry SM, Pirih FQ, Soundia A, Cunha FQ, Cirelli JA, Aghaloo TL, Tetradis S.

J Bone Miner Res. 2016 Aug;31(8):1596-607. doi: 10.1002/jbmr.2827. Epub 2016 May 4.

4.

Using self-reports of pain and other variables to distinguish between older women with back pain due to vertebral fractures and those with back pain due to degenerative changes.

Clark EM, Gooberman-Hill R, Peters TJ.

Osteoporos Int. 2016 Apr;27(4):1459-67. doi: 10.1007/s00198-015-3397-2. Epub 2015 Nov 13.

5.

Long-term efficacy, safety, and patient acceptability of ibandronate in the treatment of postmenopausal osteoporosis.

Inderjeeth CA, Glendenning P, Ratnagobal S, Inderjeeth DC, Ondhia C.

Int J Womens Health. 2014 Dec 17;7:7-17. doi: 10.2147/IJWH.S73944. eCollection 2015. Review.

6.

Bazedoxifene versus oral bisphosphonates for the prevention of nonvertebral fractures in postmenopausal women with osteoporosis at higher risk of fracture: a network meta-analysis.

Ellis AG, Reginster JY, Luo X, Cappelleri JC, Chines A, Sutradhar S, Jansen JP.

Value Health. 2014 Jun;17(4):424-32. doi: 10.1016/j.jval.2014.01.008. Epub 2014 May 5.

7.

Effects of clodronate and alendronate on osteoclast and osteoblast co-cultures on silk-hydroxyapatite films.

Hayden RS, Vollrath M, Kaplan DL.

Acta Biomater. 2014 Jan;10(1):486-93. doi: 10.1016/j.actbio.2013.09.028. Epub 2013 Oct 1.

8.

The role of the combination of bone and fall related risk factors on short-term subsequent fracture risk and mortality.

Huntjens KM, van Geel TA, van Helden S, van den Bergh J, Willems P, Winkens B, Geusens PP, Brink PR.

BMC Musculoskelet Disord. 2013 Apr 4;14:121. doi: 10.1186/1471-2474-14-121.

9.
10.

Determinants of fracture risk in a UK-population-based cohort of older women: a cross-sectional analysis of the Cohort for Skeletal Health in Bristol and Avon (COSHIBA).

Clark EM, Gould VC, Morrison L, Masud T, Tobias J.

Age Ageing. 2012 Jan;41(1):46-52. doi: 10.1093/ageing/afr132. Epub 2011 Nov 21.

11.

Effects of D-003 (10 mg/day) on bone mineral density of the lumbar spine and femoral neck in postmenopausal women: a randomized, double-blinded study.

Ceballos A, Castaño G, Mendoza S, González J, Mas R, Fernández L, Illnait J, Mesa M, Gámez R, Fernández JC, Telles R, Marrero D, Eng MG, Ruiz D, Jardines Y.

Korean J Intern Med. 2011 Jun;26(2):168-78. doi: 10.3904/kjim.2011.26.2.168. Epub 2011 Jun 1.

12.

Osteoimmunopathology in HIV/AIDS: A Translational Evidence-Based Perspective.

Barkhordarian A, Ajaj R, Ramchandani MH, Demerjian G, Cayabyab R, Danaie S, Ghodousi N, Iyer N, Mahanian N, Phi L, Giroux A, Manfrini E, Neagos N, Siddiqui M, Cajulis OS, Brant XM, Shapshak P, Chiappelli F.

Patholog Res Int. 2011;2011:359242. doi: 10.4061/2011/359242. Epub 2011 May 21.

13.

Updated recommendations for the diagnosis and management of osteoporosis: a local perspective.

Raef H, Al-Bugami M, Balharith S, Moawad M, El-Shaker M, Hassan A, Al-Shaikh A, Al-Badawi I; King Faisal Specialist Hospital Osteoporosis Working Group.

Ann Saudi Med. 2011 Mar-Apr;31(2):111-28. doi: 10.4103/0256-4947.77502.

14.

Lateral back pain identifies prevalent vertebral fractures in post-menopausal women: cross-sectional analysis of a primary care-based cohort.

Clark EM, Hutchinson AP, McCloskey EV, Stone MD, Martin JC, Bhalla AK, Tobias JH.

Rheumatology (Oxford). 2010 Mar;49(3):505-12. doi: 10.1093/rheumatology/kep414. Epub 2009 Dec 16.

15.

Prevention of osteoporosis-related fractures among postmenopausal women and older men.

Rahmani P, Morin S.

CMAJ. 2009 Nov 24;181(11):815-20. doi: 10.1503/cmaj.080709. Epub 2009 Oct 19. Review. No abstract available.

16.

Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture.

Chapurlat RD.

Ther Clin Risk Manag. 2009 Apr;5(2):169-75. Epub 2009 May 4.

17.
19.

Treating osteoporosis in Canada: what clinical efficacy data should be considered by policy decision makers?

Adachi JD, Kennedy CC, Papaioannou A, Ioannidis G, Leslie WD, Walker V.

Osteoporos Int. 2009 Oct;20(10):1785-93. doi: 10.1007/s00198-009-0870-9. Epub 2009 Mar 11.

20.

Phosphate: known and potential roles during development and regeneration of teeth and supporting structures.

Foster BL, Tompkins KA, Rutherford RB, Zhang H, Chu EY, Fong H, Somerman MJ.

Birth Defects Res C Embryo Today. 2008 Dec;84(4):281-314. doi: 10.1002/bdrc.20136. Review.

Supplemental Content

Support Center